News

ITALY, Torino, December 9th, 2021. ELITechGroup announced today that its SARS-CoV-2 Extended ELITe MGB® Kit reliably differentiates the SARS-CoV-2 Omicron (B.1.1.529) variant from other variants of concern. The in-silico analysis was confirmed by testing patient samples positive for different SARS-CoV-2 variants including Omicron. ELITechGroup is pleased to offer the SARS-CoV-2…

ITALY, Torino, August 3rd, 2021. ELITechGroup is pleased to announce the CE mark for use of saliva on SARS-CoV-2 ELITe MGB® Kit. The collection of saliva matrix is less invasive for SARS-CoV-2 detection than nasopharyngeal swabs and will permit to address different needs starting from repeated screening in various settings…

ITALY, Torino, March 18th, 2021. ELITechGroup is pleased to announce the release of SARS-CoV-2 Variants ELITe MGB® Kit. The Kit is for Research Use Only and is intended as a reflex test for the qualitative detection and discrimination of the mutations N501Y and E484K of the S gene of SARS-CoV-2…

ITALY, Torino, December, 15th, 2020. ELITechGroup is pleased to announce the release of SARS-CoV-2 PLUS ELITe MGB® Kit. The Kit is CE-IVD marked and detects SARS-CoV-2, Flu A, Flu B, and RSV on the Sample-to Result-Platform ELITe InGenius® and is available on major PCR thermocyclers as well. The test will…

Turin, 20 May, 2020 – It is with great satisfaction that ELITechGroup announces the installation of the ELITe InGenius® number 500, the fully automated “Sample – to – Result” Real Time PCR platform. ELITe InGenius® with its outstanding flexibility is increasingly recognized as a reliable system in molecular diagnostics. The…

ITALY, Torino, Feb, 26, 2020. ELITechGroup is pleased to announce the release of the kit GeneFinderTM COVID-19 Plus RealAmp Kit, the Kit is CE – IVD and permits to detect Sars-CoV-2 as well known as Coronavirus, Real-time PCR assay on a Sample to Result Platform: ELITe InGenius® The kit detects…

Milan, Italy – June 27th, 2019 – ELITechGroup was presented with the prestigious Le Fonti Award on June 27th for outstanding Health & Pharma Category at Palazzo Mezzanotte in Milan. LeFonti AWARDS® is a live streaming ceremony recognizing organizations that demonstrate corporate excellence in the fields of business innovation, leadership,…

A few words about us… Il Sole 24 ORE listed ELITechGroup SpA among the most important italian companies in IVD&Medical Device. ELITechGroup SpA – Article 201906

The ELITe Macrolide R/MG can detect Mycoplasma Genitalium and the five different mutations, which are responsible for macrolide resistance: A2058G, A2059G, A2058T, A2058C en A2059C. No sample preparation CE-IVD validated in urine Liquid ready-to-use monoreagent In combination with the ELITe InGenius and the STI PLUS kit (CT/NG/MG/TV), the Macrolide-R/MG ELITe…

EMD PR EG Biopharm 201804

ELITechGroup Molecular Diagnostics is very pleased to inform you about to this participation in the 28th ECCMID congress in Madrid and provides you more information about the event. ECCMID BOOTH (Booth # 32) The 2 topics are promoted this year by the Molecular Diagnostics : ELITe InGenius menu: the largest…

Read our press release to learn more >>> click here“

Puteaux, France, 12th February 2017 – ELITechGroup Molecular Diagnostics announces today the launch of a high-performance multiplex assay, Respiratory Bacterial ELITe MGB® Panel, for the diagnosis of bacterial respiratory infections, validated with ELITe InGenius®, ELITechGroup’s fully automated sample to result system. Respiratory infections are common causes of morbidity and mortality…

Puteaux, France, 9th June 2017 – ELITechGroup Molecular Diagnostics announces the CE-IVD marking of the STI ELITe MGB® Panel: a multiplex assay for the detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and Mycoplasma genitalium (MG), three major bacteria involved in Sexually Transmitted Infections. STIs are a global burden with more than 1…